Objectives Cancer is increasingly classified according to biomarkers that drive tumour growth and therapies developed to target them. In rare biomarker-defined cancers, randomised controlled trials to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback